Sens. Urge Watchdogs To Inspect $53B Valeant-Allergan Play

Sens. Urge Watchdogs To Inspect $53B Valeant-Allergan Play

More than a half-dozen U.S. senators on Thursday asked competition regulators to review the buzzed-about $53 billion merger proposal that would fold Botox maker Allergan Inc. into Valeant Pharmaceuticals International Inc., saying the transaction could ...read more

  • Tags: